Gambro AB Purchase Puts a Dent in Baxter International, Inc.'s Third-Quarter Earnings

Published: Oct 17, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Medical products maker Baxter International Inc reported a 7 percent fall in third-quarter earnings, hurt by charges related to its $4 billion acquisition of Swedish dialysis products company Gambro AB. Net earnings fell to $544 million, or 99 cents per share, from $583 million, or $1.06 per share, a year earlier. Excluding special items, the maker of dialysis equipment, drug infusion pumps and blood therapy products reported earnings of $1.19 per share.

Help employers find you! Check out all the jobs and post your resume.

Back to news